A Framework of Critical Considerations in Clinical Exome Reanalyses by Clinical and Laboratory Standards Institute

J Mol Diagn. 2022 Feb;24(2):177-188. doi: 10.1016/j.jmoldx.2021.11.004.


Exome reanalysis is useful for providing molecular diagnoses for previously uninformative samples. However, challenges exist in implementing a practical solution for clinicians and laboratories. This study complements the current literature by providing practical considerations for patient-level and cohort-level reanalyses. The Clinical and Laboratory Standards Institute assembled the Document Development Committee and an interpretation working group that developed the framework for reevaluation of exome-based data. We describe two distinct but complementary approaches toward exome reanalyses: clinician-initiated patient-level reanalysis, and laboratory-initiated cohort-level reanalysis. We highlight the advantages and constraints for both approaches, and provide a high-level conceptual guide for ordering clinicians and laboratories through the critical decision pathways. Because clinical exome sequencing continues to be the standard of care in genetics, exome reanalysis would be critical in increasing the overall diagnostic yield. A systematic guide will facilitate the efficient adoption of reevaluation of exome data for laboratories, health care professionals, genetic counselors, and clinicians.

MeSH terms

  • Clinical Laboratory Services*
  • Exome Sequencing
  • Exome* / genetics
  • Humans
  • Laboratories
  • Laboratories, Clinical